Pharma giant MSD is buying the Dundalk-based vaccines plant of Chinese rival Wuxi in a €500 million deal. Wuxi invested €200 million in 2019 to build the plant, which currently employs 200 people, ...

Being Tested in Combination with MSD’s anti-PD-1 Therapy, KEYTRUDA® (pembrolizumab)CAMBRIDGE, United Kingdom, Sept. 17, 2025 ...

Medicines giant MSD has officially opened expanded facilities at its Carlow vaccines plant as well as a new biologics unit in Dunboyne, Co Meath. The company, known in the United States as Merck, said ...

MSD is slashing $3bn (€2.59bn) from its annual spending as it braces for off-brand competition to its Irish-manufactured cancer drug Keytruda, the best-selling medicine in the world. The drugmaker ...

Motor Sport Developments has announced that it is ready to begin a 'rigorous testing programme' with the new Corsa Super 2000 car. In a statement to the press the Milton Keynes-based company added ...

Antibody-drug conjugates (ADCs) and other next-generation drug modalities are unlocking new treatment possibilities. However, ...

Company hopes to build plant alongside existing one, creating 300 construction jobs over 18 months Workers at the MSD plant in Ballydine Pharmaceutical giant MSD, which is part of the US group Merck, ...